PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Wakayama Medical University Kihoku Hospital, Wakayama 6497113, Japan.\', \'Department of Hematology/Oncology, Wakayama Medical University, Wakayama 6418509, Japan.\', \'Department of Internal Medicine III, Wakayama Medical University, Wakayama 6418509, Japan.\', \'Department of Neurology, Wakayama Medical University, Wakayama 6418509, Japan.\', \'Department of Nephrology, Wakayama Medical University, Wakayama 6418509, Japan.\', \'Department of Nursing, Wakayama Medical University Kihoku Hospital, Wakayama 6497113, Japan.\', \'Department of Pharmacy, Wakayama Medical University Kihoku Hospital, Wakayama 6497113, Japan.\', \'Department of Infection Control and Prevention, Wakayama Medical University, Wakayama 6418509, Japan.\', \'Second Department of Surgery, Wakayama Medical University, Wakayama 6418509, Japan.\', \'Department of Neurosurgery, Wakayama Medical University, Wakayama 6418509, Japan.\', \'Wakayama Prefecture, Health Department, Wakayama 6408585, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 11810.3390/medicina58010118
?:hasPublicationType
?:journal
  • Medicina (Kaunas, Lithuania)
is ?:pmid of
?:pmid
?:pmid
  • 35056426
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.422
?:rankingScore_hIndex
  • 29
?:title
  • Risk Factors for Therapeutic Intervention of Remdesivir in Mild to Moderate COVID-19-A Single-Center Retrospective Study of the COVID-19 Fourth Pandemic Period in Wakayama, Japan.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all